InsiderTrades

Form 4 for LRCX Lam Research

Accepted 2021-10-27 00:00:00 ET · period of report 2021-10-25 · accession 0000707549-21-000157 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2021-10-27 2021-10-25 LRCX Bettinger Douglas R CFO, EVP M - OptEx $80.60 +9,303 84.7K +12% +$749.8K
D 2021-10-27 2021-10-25 LRCX Bettinger Douglas R CFO, EVP S - Sale+OE $555.21 -5,295 79.4K -6% -$2.94M
D 2021-10-27 2021-10-25 LRCX Bettinger Douglas R CFO, EVP M - OptEx $80.60 +9,303 0 New +$749.8K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2021-10-25 M A 9,303 $80.60 84,722 D — — (F1) The amount reported includes shares subject to unvested restricted stock units.
2 Common Common Stock 2021-10-25 S D 5,295 $555.21 79,427 D — — (F1) The amount reported includes shares subject to unvested restricted stock units.
3 Derivative Employee Stock Option (Right to Buy) 2021-10-25 M A 9,303 $80.60 0 D $80.60 · — to 2022-02-11 9,303 Common Stock (F2) The stock options became exercisable in three equal installments on 03/01/2016, 03/01/2017, and 03/01/2018.